Nathaniel Kenton is an accomplished medicinal chemist with extensive experience in drug discovery, particularly focusing on antivirals and treatments for rare genetic diseases. Currently serving as Principal Investigator in Medicinal Chemistry at PostEra since January 2023, Nathaniel previously held roles at Enanta Pharmaceuticals from June 2019 to January 2023, where Nathaniel advanced from Scientist to Senior Scientist in the same field. Prior experience includes a Scientist I position at PTC Therapeutics, Inc., and a Graduate Teaching Assistant role at The Ohio State University, where Nathaniel conducted research on the total synthesis of complex natural products. Educational qualifications include a Ph.D. in Organic Chemistry from The Ohio State University, along with an MS and a BS in Chemistry from Northeastern University.
This person is not in any teams
This person is not in any offices